A Green Plastics Twofer

I first became aware of starch-based plastics in 2005 when I encountered tiny Cereplast's deal to provide disposable plasticware for ARAMARK, the folks that run the food service at ball games. The idea was nice, but the company was so tiny and speculative that I shelved it as an investment possibility.

Jack Uldrich's piece on biodegradable plastics rekindled my interest, and I've been following the major players in the space more carefully ever since. Two recent news items stand out.

You're watching the German people's court
Metabolix (Nasdaq: MBLX  ) is a company that uses bacteria to generate sugar-based plastics. The company, which IPO'd in November, relies on technology licensed from MIT. Other MIT startups range from Akamai (Nasdaq: AKAM  ) to Acusphere to American Superconductor (Nasdaq: AMSC  ) .

A key test for any IP-heavy business is the patent litigation process. Metabolix faced just such a test this month in Germany, where a Procter & Gamble (NYSE: PG  ) subsidiary challenged Metabolix's patent in court. The suit was dismissed. A great relief to the company, no doubt, but this is probably just the first of many court battles that Metabolix will face as a high-profile public company.

Taking the Petro out of Petrochemical
Top Brazilian petrochemical firm Braskem (NYSE: BAK  ) made headlines on Thursday with its announcement of a 100% renewable polyethylene. Naturally, this competing product is derived from ethanol, Brazil's specialty. It won't be produced in commercial quantities until late 2009 at the earliest.

Braskem is an interesting entrant; it's both large enough and experienced enough to roll out its product without the help of a partner. In contrast, Cereplast is working with an Alcoa (NYSE: AA  ) subsidiary, while Metabolix is hitched to Archer Daniels Midland (NYSE: ADM  ) . The problem with the Metabolix-ADM joint venture, dubbed Telles, is that while ADM makes perfect sense as a feedstock supplier, it's not a plastics company. Plastics experience, combined with access to a cheap sugar cane-derived feedstock, could put Braskem out in front of the pack, especially if it hits its production target, which is a full four times that of Telles' 110 million-pound goal. This contest ought to sustain our interest for years to come.

Related Foolishness:

Fool contributor Toby Shute doesn't own shares in any company mentioned. Akamai is a Rule Breakers pick. There's nothing unsustainable about the Motley Fool's disclosure policy.


Read/Post Comments (0) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 530173, ~/Articles/ArticleHandler.aspx, 12/17/2014 3:12:15 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement